TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05357664

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Total Hip Arthroplasty
Description: Pinnacle acetabular shells used with PINNACLE DM Metal liner and BIMENTUM ALTRX PE liner with DePuy metal or ceramic heads and DePuy femoral prostheses

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Revision Total Hip Arthroplasty
Description: Pinnacle acetabular shells used with Pinnacle DM Metal liner and BIMENTUM ALTRX PE liner with DePuy metal or ceramic heads and DePuy femoral prostheses
Study: NCT05540769

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: catheter guided ASD closure
Description: transcatheter secundum ASD device closure
Study: NCT06178536

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Consumption
Description: The surgery will be done using a bone consumption protocol

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Bone Consumption
Description: The surgery will be done using a bone consumption protocol

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone expansion
Description: implants will be placed after a bone expansion protocol

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Bone expansion
Description: implants will be placed after a bone expansion protocol
Study: NCT05199506

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: RAP
Description: Treatment of cellulite with RAP device
Study: NCT05847452

Intervention type: DRUG
Intervention: Benralizumab
Description: 30mcg ever month for 3 months
Study: NCT05548049

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Bone harvesting from ramus area with piezosurgery for autogenous bone augmentation
Description: In this invervention, the piezo-surgical device settings were set to irrigation: '4', function: 'cortical', light: 'auto'. After the full-thickness flap was lifted with the periosteal elevator, superior and vertical osteotomies were performed with the OT-12 piezo-surgical tip. Lower horizontal osteotomies were performed using OT8-L or OT-8-R piezo tips according to the studied quadrant, combining the vertical osteotomy.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Bone harvesting from ramus area with conventional burs for autogenous bone augmentation
Description: In control group, After the full-thickness flap is lifted with the periosteal elevator, using a thin #9 fissure burand the surgical handpiece S-11 Straight tip , the physiodispenser settings are according to the manufacturer's recommendations. The osteotomy was performed after it was adjusted to 40,000 rpm as appropriate. Bone incisions were completed with a round bur to combine the lower horizontal osteotomies and 2 vertical osteotomies. The osteotomies were completed with the help of a thin flat drill, and the block graft was carefully separated from the donor site.
Study: NCT05820698

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The Mediterranean style diet
Description: Participants in the Mediterranean style diet group will be provided with recommendations to include a minimum of 5 servings of fruits and vegetables (combined) per day, 2 servings of whole grains per meal per day, at least two servings of extra virgin olive oil per day, a maximum two servings of dairy products per day (excluding milk in coffee/tea), a minimum of 3 servings of fish per week (of which two should be oily fish), less than 2 servings of red meat or processed meat per week. Confectionary and sugar sweetened beverages should be limited to less than 2 servings per week.~Participants randomised to the Mediterranean style intervention will be provided with support documents including a dietary guideline booklet, recipes, meal plans, shopping and product swap lists, as well as eating-out and budget-eating advice sheets. Food deliveries containing key food items of the diet intervention will be scheduled for week 1, week 4, and week 8 of the study.
Study: NCT04395521

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Diabetic foot self-management support
Description: Daily educational organic or inorganic posts (2 to 5) released in a timed sequence through a Hootsuite application plus peer interactions/support for three months.
Study: NCT05820698

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The Mediterranean style diet
Description: Participants in the Mediterranean style diet group will be provided with recommendations to include a minimum of 5 servings of fruits and vegetables (combined) per day, 2 servings of whole grains per meal per day, at least two servings of extra virgin olive oil per day, a maximum two servings of dairy products per day (excluding milk in coffee/tea), a minimum of 3 servings of fish per week (of which two should be oily fish), less than 2 servings of red meat or processed meat per week. Confectionary and sugar sweetened beverages should be limited to less than 2 servings per week.~Participants randomised to the Mediterranean style intervention will be provided with support documents including a dietary guideline booklet, recipes, meal plans, shopping and product swap lists, as well as eating-out and budget-eating advice sheets. Food deliveries containing key food items of the diet intervention will be scheduled for week 1, week 4, and week 8 of the study.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: The UK diet
Description: Participants in the UK diet with time-restricted eating group will be provided with recommendations of a nutritionally balanced diet, corresponding to the average intakes of the UK population. Participants will be advised to consume no more than 4 portions of fruits and vegetables combined per day, to have at least two servings of dairy per day, to limit the consumption of white fish to less than 1 serving per week, with ≤1 serving of oily fish per month. Nuts and seeds consumption should also be limited to ≤1 serving per week and at least 3 servings of white and red meat should be consumed per week.~Participants randomised to the UK diet will be provided with support documents including a dietary guideline booklet, recipes, and meal plans. A £30 reimbursement will be provided to participants for their grocery shopping on week 1, week 4, and week 8 of the study.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Time-restricted eating
Description: Participants randomised to the time-restricted eating interventions will be advised to limit food intake to a 10-hour eating window and to abstain from food intake for a 14-hour fasting window. Hydration is to be maintained during the fasting window with water and/or plain teas/coffees

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Time-restricted eating
Description: Participants randomised to the time-restricted eating interventions will be advised to limit food intake to a 10-hour eating window and to abstain from food intake for a 14-hour fasting window. Hydration is to be maintained during the fasting window with water and/or plain teas/coffees
Study: NCT05179083

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High-Impact Aerobic Exercise
Description: Participants will be submitted to a 12-week high-impact aerobic exercise program using a recliner bike with three sessions per week. The exercise protocol takes 45 minutes per session and consists of five minutes of warm-up, 30 minutes of cycling with progressive increase in intensity until the target heart rate (80% of maximum) is reached, followed by 10 minutes of cool down.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Low-Impact Aerobic Exercise
Description: Participants will be submitted to a 12-week low-impact aerobic exercise program using a recliner bike with three sessions per week. The exercise protocol takes 45 minutes per session and consists of five minutes of warm-up, 30 minutes of cycling with progressive increase in intensity until the target heart rate (40% of maximum) is reached, followed by 10 minutes of cool down.
Study: NCT05039671

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Measurement-based care (MBC)
Description: Clinicians will receive a 3-hour interactive MBC training followed by six months of post-training consultation. Training and consultation will include how to collect, score, and use student- and parent-reported progress measures with students and families to inform collaborative progress monitoring and treatment decisions.
Study: NCT04814368

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: canakinumab
Description: intra-articular injection (into the knee)

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: canakinumab
Description: intra-articular injection (into the knee)

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: LNA043
Description: intra-articular injection (into the knee)

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: LNA043
Description: intra-articular injection (into the knee)

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo to canakinumab
Description: intra-articular injection (into the knee)

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo to canakinumab
Description: intra-articular injection (into the knee)
Study: NCT06461533

Intervention type: DRUG
Intervention: Susoctocog Alfa (Genetical Recombination)
Description: Susoctocog Alfa (Genetical Recombination), Intravenous injection
Study: NCT05202509

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Obicetrapib
Description: 10mg obicetrapib tablet

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo tablet to resemble obicetrapib
Study: NCT05248542

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual Reality Usage on Oral Care Knowledge
Description: Virtual Reality Usage on Oral Care Knowledge about independent older adults
Study: NCT04041804

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: semirapid maxillary expansion (SRME)
Description: A Banded Hyrax is going to be used in order to provide an increase in the maxillary transverse dimension

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: semirapid maxillary expansion (SRME)
Description: A Banded Hyrax is going to be used in order to provide an increase in the maxillary transverse dimension
Study: NCT06430203

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Peer mentoring
Description: Indigenous young adult peer mentors who will develop and deliver the program based on needs and wants of our participants. The program will be built on their experience and ideas. They will be empowered to guide the program in the direction they see best for their communities.
Study: NCT04888156

Intervention type: OTHER
Intervention: Unchanged treatment
Description: Treatment is the same pre- and post self-tonometry
Study: NCT05649891

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Emergency Manual
Description: Collection of crisis checklists and fact sheets
Study: NCT05376397

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: iTHRIVE 365
Description: iTHRIVE 365 is a multicomponent intervention that combines mHealth features and institutional to support community priorities identified in formative CBPR. In line with best-practices for trials of intervention principles (TIPs) of interventions with mHealth features, THRIVE 365 deploys intervention elements that serve to accomplish intervention strategies. THRIVE 365 intervention strategies are to promote: 1)Health knowledge and motivation; 2)Social support coping; 3)Access to culturally-affirming healthcare; and 4)Housing and other economic resources. THRIVE 365 pursues these strategies via these intervention elements: 1)Weekly HIV and psychological health information and motivation content and daily health notifications; 2)Online moderated forums, interpersonal chats, and community calendars; 3)Linkage to biopsychosocial healthcare via THRIVE SS's network of BSMM-affirming providers; and 4)Housing and economic resources through THRIVE SS's direct support and referral network.
Study: NCT04671875

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Recombinant Humanized Monoclonal Antibody MIL93
Description: PART I :The patients confirming to the eligibility criteria will be assigned to the 6 dose groups (0.3mg/kg, 1mg/kg, 3mg/kg, 10mg/kg, 20mg/kg, 30mg/kg,respectively) based on the sequence of inclusion. Each patient will receive an intravenous infusion of MIL93 every 3 or 2 week on Day 1.~PART II:One recommended dose will be conducted from 6 dose groups based on results of PART I.
Study: NCT04806100

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Malleo-Lok
Description: The Malleo-Lok is a novel, low-profile carbon fiber device with two laterally positioned struts aligned in the sagittal plane.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Malleo-Lok
Description: The Malleo-Lok is a novel, low-profile carbon fiber device with two laterally positioned struts aligned in the sagittal plane.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Malleo-Lok
Description: The Malleo-Lok is a novel, low-profile carbon fiber device with two laterally positioned struts aligned in the sagittal plane.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Malleo-Lok
Description: The Malleo-Lok is a novel, low-profile carbon fiber device with two laterally positioned struts aligned in the sagittal plane.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Malleo-Lok
Description: The Malleo-Lok is a novel, low-profile carbon fiber device with two laterally positioned struts aligned in the sagittal plane.
Study: NCT04888156

Intervention type: OTHER
Intervention: Changed treatment
Description: Treatment is changed post self-tonometry
Study: NCT04806100

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Malleo-Lok
Description: The Malleo-Lok is a novel, low-profile carbon fiber device with two laterally positioned struts aligned in the sagittal plane.
Study: NCT05277285

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sodium Thiosulfate 25% Solution for Injection
Description: The drug will be administered via continuous infusion after being diluted to a concentration 12.5 gr/100ml

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sodium Thiosulfate 25% Solution for Injection
Description: The drug will be administered via continuous infusion after being diluted to a concentration 12.5 gr/100ml
Study: NCT05846542

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Video-game based therapy
Description: Video-game based therapy will be designed for the individual basis for the upper extremity.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional physiotherapy
Description: Conventional physiotherapy within a specific program

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional physiotherapy
Description: Conventional physiotherapy within a specific program
Study: NCT06128642

Intervention type: DEVICE
Intervention: Toe separator orthosis
Description: The orthoses to be used during the study will be randomly distributed to the individuals participating in the study. Foot pressure analysis will be evaluated after the participants use the toe separation orthosis for 8 hours a day, for a total of 1 month.~Plantar pressure analysis will be performed again without orthosis, with orthosis and 1 month after the use of orthosis. Additionally, patient orthosis satisfaction evaluation will be made at the end of the 1-month period during which the participants use the orthoses.
Study: NCT00415649

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VRC-HIVDNA016-00-VP

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VRC-HIVADV014-00-VP

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Vaccine placebo
Description: Placebo comparator
Study: NCT04454476

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trametinib treatment
Description: 1 mg taken by mouth once a day for 14 days

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endoscopy
Description: A tiny camera on the end of a long, flexible tube will be used to examine the stomach and take biopsies.
Study: NCT06128642

Intervention type: DEVICE
Intervention: Dynamic orthosis
Description: The orthoses to be used during the study will be randomly distributed to the individuals participating in the study. Foot pressure analysis will be evaluated after participants use the dynamic orthosis for 8 hours a day, for a total of 1 month.~Plantar pressure analysis will be performed again without orthosis, with orthosis and 1 month after the use of orthosis. Additionally, patient orthosis satisfaction evaluation will be made at the end of the 1-month period during which the participants use the orthoses.
Study: NCT05037305

Intervention type: OTHER
Group type: OTHER
Intervention: Educational video
Description: The brief educational video provides information about pharmacogenetic testing, the results of pharmacogenetic testing, and how to find these results in the patient portal.

Intervention type: OTHER
Group type: OTHER
Intervention: Educational video
Description: The brief educational video provides information about pharmacogenetic testing, the results of pharmacogenetic testing, and how to find these results in the patient portal.
Study: NCT05350150

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Auricular Vagal Nerve Stimulation
Description: The Parasym device will be placed on the patient's left tragus to provide transcutaneous electrical stimulation to the auricular branch of the vagus nerve.
Study: NCT06526637

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Paper Package
Description: Paper based (as per current practice at Central and North West London (CNWL) NHS Foundation Trust) version of Palliate.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: V1 + Preparation Sheet
Description: Paper based version of Palliate plus a preparation sheet, that provides visual cues as to what equipment is required for the preparation and administration of the medications.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: V2 + Video Training
Description: Hybrid - paper based materials, preparation sheet, and video instructions available via an interactive portable document format (PDF) version of the training materials.
Study: NCT06193837

Intervention type: DRUG
Intervention: Augmentin
Description: Use of prophylactic antibiotics in lap cholecystectomy
Study: NCT05883930

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 'Let's Move' program
Description: Students will complete data collection forms as part of the program. According to International Physical Activity Questionnaire (IPAQ), those who are low in activity and inactive will be assigned to the appropriate intervention program based on their sedentary lifestyle stage.~Students will enter the module system prepared according to the five different stages of change \[not thinking (1), thinking (2), preparing (3), acting (4), continuing (5)\] of sedentary living.~There are 12 different initiatives for each phase/module of the program. Summary and reinforcing questions are asked at the end of each trial. If participants do not answer the questions, they cannot continue with the next week's initiative.~Participants' daily step counts with the smart wristband are recorded in the program.~Daily alerts/reinforcement messages related to that week's initiative will be sent during all phases.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: no intervention
Description: No intervention will be applied to the control group.
Study: NCT06180590

Intervention type: DRUG
Intervention: Sofosbuvir / Velpatasvir / Voxilaprevir Oral Tablet [Vosevi]
Description: Evaluate the efficacy of Vosevi in DAAs-experienced patients

Intervention type: DRUG
Intervention: Sofosbuvir / Velpatasvir / Voxilaprevir Oral Tablet [Vosevi]
Description: Evaluate the efficacy of Vosevi in DAAs-experienced patients
Study: NCT06166498

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: SP (Macleods Pharmaceuticals Ltd)
Description: Children who weigh \<10kg will receive Sulfadoxine-pyrimethamine paediatric formulation (250mg/12.5mg) dispersable tablets; children who weigh \>10kg will receive 500mg sulfadoxine plus 25mg pyrimethamine

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: AS (Guilin Pharmaceuticals)
Description: Children will receive 4 mg/kg/day for 7 days
Study: NCT06493695

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Both EGChat and CES intervention
Description: 1. A exercise-promoting chatbot called EGChat, integrated into an established online health promotion platform.~2. Intervention of CES (Cranial Electrotherapy Stimulation) at Home

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise Chatbot
Description: Exercise Chatbot

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CES (Cranial Electrotherapy Stimulation)
Description: Intervention of CES (Cranial Electrotherapy Stimulation)
Study: NCT05099718

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: palatal soft tissue harvesting
Description: A 6x2mm palatal soft tissue graft will be harvested.

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: palatal soft tissue harvesting
Description: A 6x2mm palatal soft tissue graft will be harvested.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid
Description: application 3-times per day for 7 days

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Saline solution (placebo)
Description: application 3-times per day for 7 days
Study: NCT04444323

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 3D Telemedicine
Description: The intervention is a consultation conducted using a 3D form of telemedicine
Study: NCT04837768

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Twice-daily transvaginal progesterone supplementation
Description: Patients with serum progesterone levels \>9.2 ng/ml on the day of embryo transfer in artificial frozen cycles will receive the traditional twice-daily vaginal progesterone supplementation till 12 weeks gestation.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Twice-weekly intramuscular + Twice-daily transvaginal progesterone supplementation
Description: Patients with serum progesterone levels \<9.2 ng/ml on the day of embryo transfer in artificial frozen cycles will receive the twice-daily vaginal progesterone in addition to twice-weekly intramuscular progesterone supplementation till 12 weeks gestation.